betoptic s betaxolol 0.25% (as hydrochloride) eye drops
novartis pharmaceuticals australia pty ltd - betaxolol hydrochloride -
betoptic suspension 2.5 mg/ml eye drops susp. dropper cont.
novartis pharma sa-nv - betaxolol hydrochloride 2,8 mg/g - eq. betaxolol 2,5 mg/g - eye drops, suspension - 2,5 mg/ml - betaxolol hydrochloride 2.8 mg/g - betaxolol
betoptic suspension single dose 2.5 mg/ml eye drops susp. dropper cont.
novartis pharma sa-nv - betaxolol hydrochloride 2,8 mg/ml - eq. betaxolol 2,5 mg/ml - eye drops, suspension - 2,5 mg/ml - betaxolol hydrochloride 2.8 mg/ml - betaxolol
betoptic
novartis new zealand ltd - betaxolol hydrochloride 0.56% equivalent to betaxolol 5 mg/ml; ; ; - eye drops, solution - 0.5 % - active: betaxolol hydrochloride 0.56% equivalent to betaxolol 5 mg/ml excipient: benzalkonium chloride as 50%soln + 5% overage. equiv. to 0.1mg/ml disodium edetate dihydrate hydrochloric acid purified water sodium chloride sodium hydroxide - the treatment of ocular hypertension or chronic open angle glaucoma. may be used alone or in combination with other iop-lowering medication.
betoptic s sterile ophthalmic suspension 0.25%
novartis (singapore) pte ltd - betaxolol hcl eqv betaxolol - solution - 0.25% w/v - betaxolol hcl eqv betaxolol 0.25% w/v
betaxolol 0.25% eye drops
sigma pharmaceuticals plc - betaxolol hydrochloride - eye drops - 2.5mg/1ml
betoptic eye drops solution 0.5%w/v %w/v
pco manufacturing - betaxolol hydrochloride - eye drops solution - 0.5%w/v %w/v
betoptic eye drops solution 0.5 %w/v
g & a licensing limited - betaxolol hydrochloride - eye drops solution - 0.5 %w/v
betoptic eye drops solution 0.5 base %w/v
ltt pharma limited - betaxolol hydrochloride - eye drops solution - 0.5 base %w/v
betoptic 0.5 %w/v eye drops solution
g & a licensing limited - betaxolol hydrochloride - eye drops solution - 0.5 %w/v